Stocks or ETFs side by side: scores, returns, risk, valuation and what they hold.
| Measure | GILDGilead Sciences, Inc. | LLYEli Lilly and Company |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Drug Manufacturers - General |
| Country | United States | United States |
| Market cap | $212B | $1.3T |
| Price | $170.87 | $1432.29 |
| Last day | +0.92% | +1.44% |
, a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients.
GILD analysis and Q-Scores →Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.
LLY analysis and Q-Scores →Data as of 2026-10-13. Not investment advice.